Cargando…
Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy
Primary immunodeficiency (PID) diseases result from genetic defects of the immune system that increase a patient's susceptibility to infections. The types of infections that occur in patients with PID diseases are dictated largely by the nature of the immunodeficiency, which can be defined by d...
Autores principales: | Gernez, Yael, Baker, Mary Grace, Maglione, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939302/ https://www.ncbi.nlm.nih.gov/pubmed/30536429 http://dx.doi.org/10.1111/trf.15020 |
Ejemplares similares
-
Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients
por: Schroeder, H. W., et al.
Publicado: (2012) -
Principles of and Advances in Immunoglobulin Replacement Therapy for Primary Immunodeficiency
por: Berger, Melvin
Publicado: (2008) -
CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients
por: Schulz, Uwe, et al.
Publicado: (2016) -
Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An Overview
por: Grossi, Paolo, et al.
Publicado: (2016) -
Initiation of immunoglobulin therapy by subcutaneous administration in immunodeficiency patients naive to replacement therapy
por: Koterba, Alan P, et al.
Publicado: (2014)